InvestorsHub Logo
Followers 96
Posts 2744
Boards Moderated 0
Alias Born 09/15/2020

Re: None

Thursday, 02/10/2022 4:47:59 PM

Thursday, February 10, 2022 4:47:59 PM

Post# of 701079
So to all those investors who, reasonably, still think there's risk involved in investing in NWBO.

This is just my opinion, but based on conversations with biotech investment advisors and friends who have followed NWBO for many years.

I think that the bullish view that at current levels the stock is derisked, can be supported by looking at the UCLA combination trial. IF, and it is not my opinion that it will, DCVax-L comes out with a lukewarm result, the fact that we have seen the recent patent applications for the combo trial being filed, leads me to believe that NWBO at this time will have a decent value for Merck or any other big pharma with products similar to Keytruda. It might in fact be greater than the current fully autorized MC of around $1.4B.

Again, this is just my opinion, but I do think that the minimum value for the combination with Keytruda, is higher than the current fully authorized MC.

Have a great day.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News